• About Us
    • Overview
    • Education
    • Mission & History
    • Board of Directors
    • The Campus
    • Careers
  • Our Achievements
    • Overview
    • Cancer
    • Technology
    • Education
    • Our Planet
    • Health & Medicine
    • Physical World
  • Get Involved
    • Overview
    • Partners in Science
    • Estate & Planned Giving
    • Attend an Event
    • Gift Opportunities
  • News & Media
    • Overview
    • News & Media Archive
    • Coronavirus
    • Feature Stories
    • News Releases
    • In The News
    • Video Gallery
    • Ad Campaigns
    • Celebrating Great Minds
  • Blog
  • Contact
  • Donate
Donate
Donate
About Us tri
About Us Overview
  • Education
  • Mission & History
  • Board of Directors
  • The Campus
  • Careers
About Us

Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the benefit of humanity.

Our Achievements tri
Our Achievements Overview
  • Cancer
  • Technology
  • Education
  • Our Planet
  • Health & Medicine
  • Physical World
Our Achievements

The Weizmann Institute’s fundamental research has led to discoveries and applications with a major impact on the scientific community and on the quality of life for millions worldwide.

Get Involved tri
Get Involved Overview
  • Partners in Science
  • Estate & Planned Giving
  • Attend an Event
  • Gift Opportunities
Get Involved

Join a community of dedicated people who share the Weizmann Institute’s commitment to shaping a better world through science.

News & Media tri
News & Media Overview
  • News & Media Archive
  • Coronavirus
  • Feature Stories
  • News Releases
  • In The News
  • Video Gallery
  • Ad Campaigns
  • Celebrating Great Minds
News & Media

Learn about the Weizmann Institute’s latest groundbreaking discoveries and the American Committee’s activities across the country.

Blog tri
  • The Curiosity Review
Blog

Popular science for the curious-minded: The Curiosity Review brings discovery to life.

Contact

Search Results

  • SEARCH BY KEYWORD
  • SEARCH BY TAG
View Articles by Tag:
  • View Articles by Tag
  • Algorithims (6)
  • Alternative energy (27)
  • Alzheimers (44)
  • Archaeology (37)
  • Artificial intelligence (20)
  • Astrophysics (108)
  • Autism (22)
  • Awards (119)
  • Bacteria (107)
  • Behavior (9)
  • Biochemistry (101)
  • Biofuel (7)
  • Biology (309)
  • Biomolecular sciences (7)
  • Blood (43)
  • Brain (175)
  • Cancer (163)
  • Cancer treatment (127)
  • Central nervous system (9)
  • Chemistry (78)
  • Children (7)
  • Circadian clock (1)
  • Climate change (73)
  • Clinical trials (40)
  • Collaborations (19)
  • Community (279)
  • Computers (73)
  • Copaxone (12)
  • Coronavirus (7)
  • Culture (359)
  • Diabetes (32)
  • Earth (74)
  • Education (157)
  • Environment (92)
  • Enzymes (29)
  • Evolution (89)
  • Fertility (20)
  • Fungus (4)
  • Genetics (109)
  • Genomics (3)
  • Heart (5)
  • Heart disease (3)
  • Humanity (83)
  • Immune system (149)
  • Immunology (10)
  • Immunotherapy (34)
  • Inflammation (19)
  • Leadership (114)
  • Leukemia (12)
  • Materials (44)
  • Mathematics (62)
  • Medicine (84)
  • Memory (39)
  • Mental health (58)
  • Metabolism (51)
  • Microbiology (2)
  • Microbiome (10)
  • Molecular cell biology (9)
  • Molecular genetics (61)
  • Multiple sclerosis (12)
  • Nanoscience (33)
  • Nature (4)
  • Neurobiology (2)
  • Neuroscience (207)
  • Nutrition (72)
  • Optics (34)
  • Organs (11)
  • Parkinsons (11)
  • Personalized medicine (5)
  • Philanthropy (148)
  • Physics (139)
  • Plants (56)
  • Proteins (96)
  • Quantum computer (3)
  • Quantum physics (2)
  • Quantum theory (34)
  • Robots (8)
  • Security (21)
  • Senses (115)
  • Sensors (8)
  • Smoking (1)
  • Solar power (19)
  • Space (110)
  • Stem cells (49)
  • Technology (206)
  • Vaccine (40)
  • Virus (135)
  • Water (40)
  • Weather (1)
  • Women (115)
  • World hunger (17)
Filter by Time:
  • All
  • Past Day
  • Past Week
  • Past Month
  • Past Year
  • Past Three Years
Clear Filters

135 results for Virus

Coronavirus: The Quest for Solutions – The American Committee Hosts Prof. Sarel Fleishman
Coronavirus: The Quest for Solutions – The American Committee Hosts Prof. Sarel Fleishman

https://www.weizmann-usa.org/news-media/video-gallery/coronavirus-the-quest-for-solutions-the-american-committee-hosts-prof-sarel-fleishman/

Apr 22, 2020... As he discusses in this video, Prof. Sarel Fleishman of the Department of Biomolecular Sciences is supporting multiple lines of coronavirus research at Weizmann – including his own.

TAGS: Culture, Technology, Biology, Immune system, Virus

Coronavirus: The Quest for Solutions – Profs. Uri Alon and Ron Milo
Coronavirus: The Quest for Solutions – Profs. Uri Alon and Ron Milo

https://www.weizmann-usa.org/news-media/video-gallery/coronavirus-the-quest-for-solutions-profs-uri-alon-and-ron-milo/

Apr 26, 2020... In this videoconference hosted by Weizmann Canada, Profs. Uri Alon and Ron Milo present their bioinformatics-based exit strategy, which Prof. Milo describes as “‘biology by the numbers’ meets the coronavirus.”

TAGS: Culture, Biology, Virus, Mathematics

Coronavirus: The Quest for Solutions – Insights on Coronavirus and Exit Strategies From an Israeli Perspective
Coronavirus: The Quest for Solutions – Insights on Coronavirus and Exit Strategies From an Israeli Perspective

https://www.weizmann-usa.org/news-media/video-gallery/coronavirus-the-quest-for-solutions-insights-on-coronavirus-and-exit-strategies-from-an-israeli-perspective/

Apr 27, 2020... Public health expert Prof. Gabi Barbash outlines the pandemic’s many unknowns: How many people are asymptomatic and yet spreading the virus? Why do some patients have mild symptoms, while others become severely ill? Are recovered patients with coronavirus antibodies now immune?

TAGS: Culture, Virus

Coronavirus: The Quest for Solutions – Dr. Ori Avinoam, Blocking the Virus’s First Steps
Coronavirus: The Quest for Solutions – Dr. Ori Avinoam, Blocking the Virus’s First Steps

https://www.weizmann-usa.org/news-media/video-gallery/coronavirus-the-quest-for-solutions-dr-ori-avinoam-blocking-the-virus-s-first-steps/

Apr 28, 2020... Dr. Ori Avinoam of Weizmann’s Department of Biomolecular Sciences presents an overview of his lab’s coronavirus research. His team has created a pseudovirus, which has all the elements of the coronavirus but is not infectious.

TAGS: Virus, Vaccine

Coronavirus: The Quest for Solutions – A Science-Based Exit Strategy for COVID-19
Coronavirus: The Quest for Solutions – A Science-Based Exit Strategy for COVID-19

https://www.weizmann-usa.org/news-media/video-gallery/coronavirus-the-quest-for-solutions-a-science-based-exit-strategy-for-covid-19/

May 04, 2020... In this video, Profs. Ron Milo and Uri Alon succinctly and clearly explain their “intermittent work” strategy for restarting the economy without triggering a new wave of COVID infections.

TAGS: Culture, Technology, Biology, Virus, Mathematics, Computers

Could the Flu Become History? An Israeli Vaccine May Make It a Reality
Could the Flu Become History? An Israeli Vaccine May Make It a Reality

https://www.weizmann-usa.org/news-media/in-the-news/could-the-flu-become-history-an-israeli-vaccine-may-make-it-a-reality/

May 06, 2020... A year and a half ago, biochemist Prof. Ruth Arnon, Israel Prize recipient for medicine and past president of the Israel Academy of Sciences and Humanities, received an email from the editor of a science journal. The editor asked whether she planned to attend a conference on multiple sclerosis that was to take place a few days later. Arnon, who was one of the scientists responsible for the research that led to the MS treatment, Copaxone, said she wouldn’t be attending, but was sending a researcher from her lab at the Weizmann Institute of Science.

TAGS: Virus, Vaccine, Proteins, Clinical trials

Weizmann in Focus, Episode 13: Special Update On Coronavirus Research
Weizmann in Focus, Episode 13: Special Update On Coronavirus Research

https://www.weizmann-usa.org/news-media/video-gallery/weizmann-in-focus-episode-13-special-update-on-coronavirus-research/

Jun 02, 2020... In this special update from his home in New York City, CEO Dave Doneson discusses the Weizmann Institute’s remarkable coronavirus response. Dave shares how the Institute has rapidly shifted its focus to address the pandemic, transforming into one of the world’s leading hubs of COVID-19 research. Weizmann scientists are fighting this disease on a variety of fronts, offering hope and optimism for us all.

TAGS: Technology, Community, Biochemistry, Biology, Virus, Philanthropy, Leadership, Vaccine

Coronavirus: The Quest for Solutions – The American Committee Hosts Dr. Nir London
Coronavirus: The Quest for Solutions – The American Committee Hosts Dr. Nir London

https://www.weizmann-usa.org/news-media/video-gallery/coronavirus-the-quest-for-solutions-the-american-committee-hosts-dr-nir-london/

May 17, 2020... Dr. Nir London discusses the “COVID Moonshot” project in this videoconference. The global initiative, which currently includes nine partners, aims to develop a “cheap and safe” antiviral treatment for COVID on a much faster timeline than traditional drug discovery.

TAGS: Culture, Technology, Biology, Virus, Mathematics, Computers

This Twist on the Four-Day Workweek Could Get People Back to Work Without Causing New Outbreaks
This Twist on the Four-Day Workweek Could Get People Back to Work Without Causing New Outbreaks

https://www.weizmann-usa.org/news-media/in-the-news/this-twist-on-the-four-day-workweek-could-get-people-back-to-work-without-causing-new-outbreaks/

May 12, 2020... There’s an obvious risk to reopening the economy during the pandemic, even in places where the number of COVID-19 cases is dropping: As more people come back into contact, cases could surge again, and businesses could be forced to shut down a second time. South Korea is seeing a new spike in cases after the outbreak seemed to be under control. In China, new cases have emerged in Wuhan, the original epicenter of the virus. But an adjustment to work schedules—along with social distancing and other tools like contact tracing—could help businesses that can’t work remotely to potentially reopen safely.

TAGS: Culture, Virus, Mathematics

Four Days of Work, Followed by 10 Days of Lockdown Could Help Prevent Another Wave of Infections
Four Days of Work, Followed by 10 Days of Lockdown Could Help Prevent Another Wave of Infections

https://www.weizmann-usa.org/news-media/in-the-news/four-days-of-work-followed-by-10-days-of-lockdown-could-help-prevent-another-wave-of-infections/

May 24, 2020... Researchers have a plan to mitigate the risk of a second wave of coronavirus infections — a scenario many experts think is likely. For some, it's an alternating cycle of four days at the office, then 10 days under lockdown. For others, it's a switch-off between 50 days under stay-at-home orders and 30 days of relative freedom.
In all likelihood, these tactics won't prevent cases from rising again.

TAGS: Culture, Virus, Mathematics

First … 5 6 7 8 9 10 11 12 13 14 Last
Back Next
SHARE

Our Achievements

Learn more about remarkable Weizmann Institute achievements that are enhancing and transforming our lives.

Learn More

Support Our Flagship Projects

Help us accelerate exciting initiatives in three forward-looking fields: neuroscience, physics, and artificial intelligence.

Learn More

Newsletter

Get the latest news and breakthroughs from the Weizmann Institute of Science.

About Us
  • Education
  • Mission & History
  • Board of Directors
  • The Campus
  • Careers
Our Achievements
  • Cancer
  • Technology
  • Education
  • Our Planet
  • Health & Medicine
  • Physical World
Get Involved
  • Partners in Science
  • Estate & Planned Giving
  • Attend an Event
  • Gift Opportunities
News & Media Blog: Curiosity Review Donate Now Contact Us
Privacy Policy Gift Acceptance Policy Financial Information

©2023 American Committee for the Weizmann Institute of Science

Charity Navigator

FOR THE FOURTH CONSECUTIVE YEAR

Platinum Transparency 2023